Climb Bio, Inc.
CLYM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $83,806 | $82,304 | $116,529 |
| - Cash | $25,803 | $22,682 | $29,020 | $87,229 |
| + Debt | $352 | $639 | $474 | $532 |
| Enterprise Value | – | $61,763 | $53,758 | $29,832 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$38 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,859 | -$8,628 | -$23,018 | -$10,911 |
| % Margin | – | – | – | – |
| Net Income | -$12,888 | -$8,666 | -$20,781 | -$8,416 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.13 | -0.31 | -0.13 |
| % Growth | -46.2% | 58.1% | -138.5% | – |
| Operating Cash Flow | -$12,139 | -$11,148 | -$15,434 | -$5,521 |
| Capital Expenditures | -$109 | -$77 | $0 | $0 |
| Free Cash Flow | -$12,248 | -$11,225 | -$15,434 | -$5,521 |